|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Neoptolemos JP, Kleeff J, Michl P,
Costello E, Greenhalf W and Palmer DH: Therapeutic developments in
pancreatic cancer: Current and future perspectives. Nat Rev
Gastroenterol Hepatol. 15:333–348. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yogev O, Barker K, Sikka A, Almeida GS,
Hallsworth A, Smith LM, Jamin Y, Ruddle R, Koers A, Webber HT, et
al: p53 loss in MYC-driven neuroblastoma leads to metabolic
adaptations supporting radioresistance. Cancer Res. 76:3025–3035.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maier P, Hartmann L, Wenz F and Herskind
C: Cellular pathways in response to ionizing radiation and their
targetability for tumor radiosensitization. Int J Mol Sci.
17:1022016. View Article : Google Scholar :
|
|
5
|
Ziegler V, Henninger C, Simiantonakis I,
Buchholzer M, Ahmadian MR, Budach W and Fritz G: Rho inhibition by
lovastatin affects apoptosis and DSB repair of primary human lung
cells in vitro and lung tissue in vivo following fractionated
irradiation. Cell Death Dis. 8:e29782017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kashiwagi H, Shiraishi K, Sakaguchi K,
Nakahama T and Kodama S: Repair kinetics of DNA double-strand
breaks and incidence of apoptosis in mouse neural stem/progenitor
cells and their differentiated neurons exposed to ionizing
radiation. J Radiat Res (Tokyo). 59:261–271. 2018. View Article : Google Scholar
|
|
7
|
Adams JM and Cory S: The BCL-2 arbiters of
apoptosis and their growing role as cancer targets. Cell Death
Differ. 25:27–36. 2018. View Article : Google Scholar
|
|
8
|
Tamm I, Wang Y, Sausville E, Scudiero DA,
Vigna N, Oltersdorf T and Reed JC: IAP-family protein survivin
inhibits caspase activity and apoptosis induced by Fas (CD95), Bax,
caspases, and anticancer drugs. Cancer Res. 58:5315–5320.
1998.PubMed/NCBI
|
|
9
|
Sochalska M, Tuzlak S, Egle A and
Villunger A: Lessons from gain- and loss-of-function models of
pro-survival Bcl2 family proteins: Implications for targeted
therapy. FEBS J. 282:834–849. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mirakhor Samani S, Ezazi Bojnordi T,
Zarghampour M, Merat S and Fouladi DF: Expression of p53, Bcl-2 and
Bax in endometrial carcinoma, endometrial hyperplasia and normal
endometrium: a histopathological study. J Obstet Gynaecol. 1–6.
2018.
|
|
11
|
Murley JS, Miller RC, Weichselbaum RR and
Grdina DJ: TP53 mutational status and ROS effect the expression of
the survivin-associated radio-adaptive response. Radiat Res.
188:579–590. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Parida PK, Mahata B, Santra A, Chakraborty
S, Ghosh Z, Raha S, Misra AK, Biswas K and Jana K: Inhibition of
cancer progression by a novel trans-stilbene derivative through
disruption of microtubule dynamics, driving G2/M arrest, and
p53-dependent apoptosis. Cell Death Dis. 9:4482018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Balart J, Pueyo G, de Llobet LI, Baro M,
Sole X, Marin S, Casanovas O, Mesia R and Capella G: The use of
caspase inhibitors in pulsed-field gel electrophoresis may improve
the estimation of radiation-induced DNA repair and apoptosis.
Radiat Oncol. 6:62011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Venturutti L, Romero LV, Urtreger AJ,
Chervo MF, Cordo Russo RI, Mercogliano MF, Inurrigarro G, Pereyra
MG, Proietti CJ, Izzo F, et al: Stat3 regulates ErbB-2 expression
and co-opts ErbB-2 nuclear function to induce miR-21 expression,
PDCD4 downregulation and breast cancer metastasis. Oncogene.
2015.PubMed/NCBI
|
|
15
|
Braun DA, Fribourg M and Sealfon SC:
Cytokine response is determined by duration of receptor and signal
transducers and activators of transcription 3 (STAT3) activation. J
Biol Chem. 288:2986–2993. 2013. View Article : Google Scholar :
|
|
16
|
Arora R, Yates C, Gary BD, McClellan S,
Tan M, Xi Y, Reed E, Piazza GA, Owen LB and Dean-Colomb W:
Panepoxydone targets NF-κB and FOXM1 to inhibit proliferation,
induce apoptosis and reverse epithelial to mesenchymal transition
in breast cancer. PLoS One. 9:e983702014. View Article : Google Scholar
|
|
17
|
Zeng Z, Sun Z, Huang M, Zhang W, Liu J,
Chen L, Chen F, Zhou Y, Lin J, Huang F, et al: Nitrostyrene
derivatives act as RXRα ligands to inhibit TNFα activation of
NF-κB. Cancer Res. 75:2049–2060. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang X, Lv B, Zhang S, Dai Q, Chen BB and
Meng LN: Effects of radix curcumae-derived diterpenoid C on
Helicobacter pylori-induced inflammation and nuclear factor kappa B
signal pathways. World J Gastroenterol. 19:5085–5093. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baens M, Bonsignore L, Somers R,
Vanderheydt C, Weeks SD, Gunnarsson J, Nilsson E, Roth RG, Thome M
and Marynen P: MALT1 auto-proteolysis is essential for
NF-κB-dependent gene transcription in activated lymphocytes. PLoS
One. 9:e1037742014. View Article : Google Scholar
|
|
20
|
Nakano K and Vousden KH: PUMA, a novel
proapoptotic gene, is induced by p53. Mol Cell. 7:683–694. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ren D, Tu HC, Kim H, Wang GX, Bean GR,
Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ and Cheng EH: BID,
BIM, and PUMA are essential for activation of the BAX- and
BAK-dependent cell death program. Science. 330:1390–1393. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bryant HE, Schultz N, Thomas HD, Parker
KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ and Helleday T:
Specific killing of BRCA2-deficient tumours with inhibitors of
poly(ADP-ribose) polymerase. Nature. 434:913–917. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cook PJ, Ju BG, Telese F, Wang X, Glass CK
and Rosenfeld MG: Tyrosine dephosphorylation of H2AX modulates
apoptosis and survival decisions. Nature. 458:591–596. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chandele A, Prasad V, Jagtap JC, Shukla R
and Shastry PR: Upregulation of survivin in G2/M cells and
inhibition of caspase 9 activity enhances resistance in
staurosporine-induced apoptosis. Neoplasia. 6:29–40. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pardo FS, Su M and Borek C: Cyclin D1
induced apoptosis maintains the integrity of the G1/S checkpoint
following ionizing radiation irradiation. Somat Cell Mol Genet.
22:135–144. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Borowiec A-S, Hague F, Gouilleux-Gruart V,
Lassoued K and Ouadid-Ahidouch H: Regulation of IGF-1-dependent
cyclin D1 and E expression by hEag1 channels in MCF-7 cells: The
critical role of hEag1 channels in G1 phase progression. Biochim
Biophys Acta. 1813:723–730. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Botto S, Streblow DN, DeFilippis V, White
L, Kreklywich CN, Smith PP and Caposio P: IL-6 in human
cytomegalovirus secretome promotes angiogenesis and survival of
endothelial cells through the stimulation of survivin. Blood.
117:352–361. 2011. View Article : Google Scholar :
|
|
28
|
Hov H, Våtsveen TK, Waage A, Sundan A and
Borset M: Induction of Cyclin D1 by HGF, IGF-1 and IL-6 in a human
myeloma cell line with a t(11:14). Translocation Blood.
108:50552006.
|
|
29
|
Ravitz MJ, Yan S, Dolce C, Kinniburgh AJ
and Wenner CE: Differential regulation of p27 and cyclin D1 by
TGF-beta and EGF in C3H 10T1/2 mouse fibroblasts. J Cell Physiol.
168:510–520. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Vaira V, Lee CW, Goel HL, Bosari S,
Languino LR and Altieri DC: Regulation of survivin expression by
IGF-1/mTOR signaling. Oncogene. 26:2678–2684. 2007. View Article : Google Scholar
|
|
31
|
Wang H, Gambosova K, Cooper ZA, Holloway
MP, Kassai A, Izquierdo D, Cleveland K, Boney CM and Altura RA: EGF
regulates survivin stability through the Raf-1/ERK pathway in
insulin-secreting pancreatic β-cells. BMC Mol Biol. 11:662010.
View Article : Google Scholar
|
|
32
|
Chi HC, Tsai CY, Tsai MM, Yeh CT and Lin
KH: Roles of long noncoding RNAs in recurrence and metastasis of
radiotherapy-resistant cancer stem cells. Int J Mol Sci. 18:182017.
View Article : Google Scholar
|
|
33
|
Hage-Sleiman R, Bahmad H, Kobeissy H,
Dakdouk Z, Kobeissy F and Dbaibo G: Genomic alterations during
p53-dependent apoptosis induced by γ-irradiation of Molt-4 leukemia
cells. PLoS One. 12:e01902212017. View Article : Google Scholar
|
|
34
|
Deng WW, Hu Q, Liu ZR, Chen QH, Wang WX,
Zhang HG, Zhang Q, Huang YL and Zhang XK: KDM4B promotes DNA damage
response via STAT3 signaling and is a target of CREB in colorectal
cancer cells. Mol Cell Biochem. 449:81–90. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chishti AA, Baumstark-Khan C, Koch K,
Kolanus W, Feles S, Konda B, Azhar A, Spitta LF, Henschenmacher B,
Diegeler S, et al: Linear energy transfer modulates
radiation-induced NF-kappa B activation and expression of its
downstream target genes. Radiat Res. 189:354–370. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ménissier de Murcia J, Ricoul M, Tartier
L, Niedergang C, Huber A, Dantzer F, Schreiber V, Amé JC, Dierich
A, LeMeur M, et al: Functional interaction between PARP-1 and
PARP-2 in chromosome stability and embryonic development in mouse.
EMBO J. 22:2255–2263. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lee SL, Ryu H, Son AR, Seo B, Kim J, Jung
SY, Song JY, Hwang SG and Ahn J: TGF-β and hypoxia/reoxygenation
promote radioresistance of A549 lung cancer cells through
activation of Nrf2 and EGFR. Oxid Med Cell Longev.
2016:68234712016. View Article : Google Scholar
|
|
38
|
Tang J, Guo F, Du Y, Liu X, Qin Q, Liu X,
Yin T, Jiang L and Wang Y: Continuous exposure of non-small cell
lung cancer cells with wild-type EGFR to an inhibitor of EGFR
tyrosine kinase induces chemoresistance by activating STAT3. Int J
Oncol. 46:2083–2095. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Diluvio G, Del Gaudio F, Giuli MV,
Franciosa G, Giuliani E, Palermo R, Besharat ZM, Pignataro MG,
Vacca A, d’Amati G, et al: NOTCH3 inactivation increases triple
negative breast cancer sensitivity to gefitinib by promoting EGFR
tyrosine dephosphorylation and its intracellular arrest.
Oncogenesis. 7:422018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li C, Iida M, Dunn EF, Ghia AJ and Wheeler
DL: Nuclear EGFR contributes to acquired resistance to cetuximab.
Oncogene. 28:3801–3813. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang YN, Lee HH, Lee HJ, Du Y, Yamaguchi H
and Hung MC: Membrane-bound trafficking regulates nuclear transport
of integral epidermal growth factor receptor (EGFR) and ErbB-2. J
Biol Chem. 287:16869–16879. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tong D, Ortega J, Kim C, Huang J, Gu L and
Li GM: Arsenic inhibits DNA mismatch repair by promoting EGFR
expression and PCNA phosphorylation. J Biol Chem. 290:14536–14541.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hanada N, Lo HW, Day CP, Pan Y, Nakajima Y
and Hung MC: Co-regulation of B-Myb expression by E2F1 and EGF
receptor. Mol Carcinog. 45:10–17. 2006. View Article : Google Scholar
|
|
44
|
Lo HW, Hsu SC, Ali-Seyed M, Gunduz M, Xia
W, Wei Y, Bartholomeusz G, Shih JY and Hung MC: Nuclear interaction
of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer
Cell. 7:575–589. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lo HW and Hung MC: Nuclear EGFR signalling
network in cancers: Linking EGFR pathway to cell cycle progression,
nitric oxide pathway and patient survival. Br J Cancer. 94:184–188.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li SJ, Liang XY, Li HJ, Li W, Zhou L, Chen
HQ, Ye SG, Yu DH and Cui JW: Low-dose irradiation promotes
proliferation of the human breast cancer MDA-MB-231 cells through
accumulation of mutant P53. Int J Oncol. 50:290–296. 2017.
View Article : Google Scholar
|
|
47
|
Sumrejkanchanakij P, Tamamori-Adachi M,
Matsunaga Y, Eto K and Ikeda MA: Role of cyclin D1 cytoplasmic
sequestration in the survival of postmitotic neurons. Oncogene.
22:8723–8730. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ahmed KM, Fan M, Nantajit D, Cao N and Li
JJ: Cyclin D1 in low-dose radiation-induced adaptive resistance.
Oncogene. 27:6738–6748. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sheng L, Wan B, Feng P, Sun J, Rigo F,
Bennett CF, Akerman M, Krainer AR and Hua Y: Downregulation of
Survivin contributes to cell-cycle arrest during postnatal cardiac
development in a severe spinal muscular atrophy mouse model. Hum
Mol Genet. 27:486–498. 2018. View Article : Google Scholar :
|
|
50
|
Tamari Y, Kashino G and Mori H:
Acquisition of radioresistance by IL-6 treatment is caused by
suppression of oxidative stress derived from mitochondria after
γ-irradiation. J Radiat Res (Tokyo). 58:412–420. 2017. View Article : Google Scholar
|
|
51
|
Yang HY, Qu RM, Lin XS, Liu TX, Sun QQ,
Yang C, Li XH, Lu W, Hu XF, Dai JX, et al: IGF-1 from
adipose-derived mesenchymal stem cells promotes radioresistance of
breast cancer cells. Asian Pac J Cancer Prev. 15:10115–10119. 2014.
View Article : Google Scholar
|
|
52
|
Yang N, Han F, Cui H, Huang J, Wang T,
Zhou Y and Zhou J: Matrine suppresses proliferation and induces
apoptosis in human cholangiocarcinoma cells through suppression of
JAK2/STAT3 signaling. Pharmacol Rep. 67:388–393. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Iliopoulos D, Hirsch HA and Struhl K: An
epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and
IL6 links inflammation to cell transformation. Cell. 139:693–706.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ma J, Sawai H, Matsuo Y, Ochi N, Yasuda A,
Takahashi H, Wakasugi T, Funahashi H, Sato M and Takeyama H: IGF-1
mediates PTEN suppression and enhances cell invasion and
proliferation via activation of the IGF-1/PI3K/Akt signaling
pathway in pancreatic cancer cells. J Surg Res. 160:90–101. 2010.
View Article : Google Scholar
|
|
55
|
Chang L, Graham P, Hao J, Ni J, Deng J,
Bucci J, Malouf D, Gillatt D and Li Y: Cancer stem cells and
signaling pathways in radioresistance. Oncotarget. 7:11002–11017.
2016.
|
